gip glp 1 GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Positive impact of GIP, GLP-1

Arch Gen Psychiatry 2011, 68, 562-576, doi:10.1001/archgenpsychiatry.2011.56

What has been documented from these sources includes: Headaches, typically described as dull and short-lived Dizziness or light-headedness, particularly after injection Nausea or mild digestive discomfort, more common with oral forms Injection-site reactions including redness, swelling and irritation Appetite changes, sometimes reported as increased hunger Disrupted sleep when dosed in the evening Less commonly, palpitations or mood changes None of these has been formally linked to BPC-157 in peer-reviewed human studies

SKIN&LAB Glutathione Ampoule Toner ,

K.YeongK

Feel as if your health care system neglects you

Data is available from the corresponding author on reasonable request